Company Filing History:
1 out of 12 
1 out of 1 Years Active: 2014-2015
Title: Scott Greenfield: Innovator in Medicinal Chemistry
Introduction
Scott Greenfield is a notable inventor based in Delmar, NY (US), recognized for his contributions to medicinal chemistry. He holds 2 patents that focus on innovative processes for synthesizing compounds with significant therapeutic applications.
Latest Patents
One of Scott's latest patents involves processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds. These compounds are particularly useful in developing medicinal products aimed at treating prostate cancer, including both castration-resistant and hormone-sensitive types. Another significant patent details methods for synthesizing scyllitol and related compounds. This patent outlines efficient methods performed in all-aqueous solutions, emphasizing the recycling of reaction products to enhance process efficiency. The methods include converting inositol to scyllitol and isolating scyllitol diborate, which can be recycled to improve yield and purity.
Career Highlights
Throughout his career, Scott has worked with various companies, including Medivation Prostate Therapeutics, Inc. and Transition Therapeutics Ireland Limited. His work has significantly impacted the field of medicinal chemistry, particularly in developing treatments for prostate cancer.
Collaborations
Scott has collaborated with notable professionals in his field, including Rajendra Parasmal Jain and Remy Angelaud. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Scott Greenfield's innovative work in medicinal chemistry, particularly in synthesizing compounds for prostate cancer treatment, showcases his significant contributions to the field. His patents reflect a commitment to improving therapeutic methods and enhancing the efficiency of chemical processes.